STOCK TITAN

[SCHEDULE 13G] Scienture Holdings, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

L1 Capital Global Opportunities Master Fund, Ltd. reports beneficial ownership of 1,075,000 shares of Scienture Holdings, Inc. common stock, representing 5.55% of the outstanding class based on 19,356,180 shares cited in the issuer's prospectus supplement. The filing states the fund has sole voting and sole dispositive power over these shares and includes a standard disclaimer noting two directors of the fund, David Feldman and Joel Arber, may be deemed to have an interest but disclaim beneficial ownership except to the extent of pecuniary interest.

Positive

  • None.

Negative

  • None.

Insights

TL;DR A Cayman-domiciled fund holds a disclosed 5.55% stake with sole voting and dispositive power—material ownership but disclosed as non-control.

The stake crosses the 5% reporting threshold, making it a material position for disclosure purposes. The filing explicitly attributes sole voting and disposal authority to the fund for 1,075,000 shares, and cites the issuer's prospectus figure for shares outstanding. No transaction details, cost basis, or intent to influence control are provided beyond a certification disclaiming control-seeking purposes.

TL;DR The filing documents a meaningful passive ownership position and includes customary director disclaimers; no governance action is disclosed.

The report identifies the reporting person and its directors and includes the standard disclaimer that the directors may be deemed to beneficially own the shares but disclaim such ownership except for pecuniary interest. There is no indication in the statement of intent to change or influence issuer control, and no group affiliations are reported.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



L1 Capital Global Opportunities Master Fund, Ltd.
Signature:/s/ David Feldman
Name/Title:David Feldman, Director
Date:08/19/2025
Scienture Holdings, Inc

NASDAQ:SCNX

SCNX Rankings

SCNX Latest News

SCNX Latest SEC Filings

SCNX Stock Data

21.53M
33.79M
25.78%
1.56%
0.67%
Pharmaceutical Retailers
Pharmaceutical Preparations
Link
United States
COMMACK